Testing at India’s National Institute of Virology has confirmed a third recent Nipah virus case from India’s Kerla state, ...

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa's private sector but not yet in public clinics. The country's advisory group on ...

RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

RSV, or respiratory syncytial virus, typically is a coldlike nuisance, but it can be severe, even life-threatening, for ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine. What to know.

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisory panel plans to revisit long-settled questions about ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s Enflonsia.